Image 1
Tri-lo-sprintec Kit
Product Images NDC 0093-2140
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tri-lo-sprintec (NDC 0093-2140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This text appears to be a list of different studies with year and type of use (ever or current use) of contraceptives. Additionally, there is a table with effect estimates, but it is not clear what these estimates refer to.*
Image 3
Image 4
options are listed*
Image 5
Image 6
Tri-Lo-Sprinteé is a triphasic regimen medication containing norgestimate and ethinyl estradiol tablets USP. The package insert includes a combination of detailed patient labeling and brief summary. The medication is manufactured by Teva Pharmaceuticals USA, Inc. and is meant for women's health. Contact details for Teva Pharmaceuticals USA, Inc. are provided in the text.*
Image 7
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
